Our previous study revealed that the expression levels of the activation molecules CD80 and CD86 on the surface of CD5+B cells were significantly elevated and correlated with the hemolytic and immune indicators in AIHA patients7. This evidence concerns the gene CD5 and autoimmune hemolytic anemia.